Theme

Tumor-type
specific Sessions

Session Title

Low grade glioma(clinical)

Presentation
No.

Abstract
No.

Lecture title

Speaker

LGGC-IS-01

SPKR-67

LGGC-O-02

LGG-49

LGGC-O-03

LGG-04

LGGC-O-04

LGG-52Binimetinib in children with progressive or recurrent low-grade glioma not associatedwith neurofibromatosis type 1: initial results from a multi-institutional phase II study

Nathan Robison

USA

LGGC-O-05

LGG-53

PNOC001 (NCT01734512): A Phase II Study of everolimus for recurrent or progressive
Sabine Mueller
pediatric low-grade gliomas (pLGG)USA

LGGC-O-06

LGG-03

Incidence and outcome of pediatric IDH-mutant glioma

Kee Kiat Yeo

USA

LGGC-O-07

LGG-20

Clinical features and treatment results for pediatric optico-hypothalamic astrocytoma

Koji Yoshimoto

Japan

LGGC-P-08

LGG-55

Outcome of BRAF V600E pediatric gliomas treated with targeted BRAF inhibition

Liana Nobre

Canada

LGGC-P-09

LGG-25

Sébastien Perreault

Canada

LGGC-P-10

LGG-27

Kathleen Dorris

USA

LGGC-P-11

LGG-18Antonella Cacchione

Italy

LGGC-P-12

LGG-11

Institutional experience of BRAF targeting therapy

Gino Bardi LolaUSALGGC-P-13

LGG-12

Trametinib for pediatric low grade gliomas: a single institution experience.

Michael Angelo Huang

USA

LGGC-P-14

LGG-01

Nahla Mobark

Saudi Arabia

LGGC-P-15

LGG-09Mariam Aboian

USA

LGGC-P-16

LGG-19Hallie Coltin

Canada

LGGC-P-17

LGG-31

LGGC-P-18

LGG-21

LGGC-P-19

LGG-26

LGGC-P-20

LGG-28Novel BRAF intragenic deletion in a glioma: a case report of a pediatric patient

Valerie Cruz

USA

LGGC-P-21

LGG-56

Infantile hemispheric brain tumor with a GOPC-ROS1 fusion gene: A case report

Rieko Taniguchi

JapanLGGC-P-22

LGG-15

Pediatric low-grade gliomas In Saudi Arabia:retrospective analysis of children with lowFahad Alamr
grade gliomas treated in King Fahad Medical City KFMC- single institutional experience

Saudi Arabia

LGGC-P-23

LGG-40Natural course and management of small asymptomatic lesion suspected of low-grade
Ai Muroiglioma in children

Japan

LGGC-P-24

LGG-05

Molecular guided therapy for a pediatric low grade glioma: A case report

Jayne VonBergen

USA

LGGC-P-25

LGG-06Long-term outcome of newly diagnosed low grade gliomaNongnuch Sirachainan

Thailand

LGGC-P-26

LGG-24

Alex Hoover

USA

LGGC-P-27

LGG-23Magimairajan Issai Vanan

Canada

LGGC-P-28

LGG-30Margot Lazow

USA

LGGC-P-29

LGG-47

Rene McNall-KnappUSA

LGGC-P-30

LGG-02

Yasushi Shibata

Japan

LGGC-P-31

LGG-36

Anne Bendel

USA

LGGC-P-32

LGG-42Nataliya Zhukova

Canada

LGGC-P-33

LGG-44

Prognostic significance of imaging characteristics in pediatric low grade gliomas

Muhammad Baig

USA

LGGC-P-34

LGG-45

A report of IDH-mutant brainstem astrocytomas in young adults

Ellen Chang

USA

LGGC-P-35

LGG-16

Julia Hoveyan

Armenia

LGGC-P-36

LGG-48

Patti Batchelder

USA

LGGC-P-37

LGG-29Treatment for recurrent optic pathway pilocytic astrocytoma

Masahiro Nonaka

Japan

LGGC-P-38

LGG-32Clinical outcome of pediatric gliomas in single institution

Hiroyuki UchidaJapan

LGGC-P-39

LGG-57Signalling mechanisms in paediatric low-grade glioma

Ankit Patel

UK

Paediatric Low Grade Gliomas: clinical management

Eric BouffetCountry

Safety and efficacy of trametinib (T) monotherapy and dabrafenib + trametinib (D+T)
Eric Bouffet
combination therapy in pediatric patients with BRAFV600-mutant low grade glioma(LGG)
A phase II re-treatment study of Selumetinib for recurrent or progressive pediatric LowJason Fangusaro
Grade Glioma (pLGG): A Pediatric Brain Tumor Consortium (PBTC) Study

A Phase 2 study of trametinib for patients with pediatric glioma with activation of theMAPK/ERK pathway. TRAM-01
Targeted therapy for pediatric low-grade gliomas and plexiform neurofibromas withtrametinib
Everolimus treatment in pediatric patients affected by low-grade gliomas (pLGG) nonTSC, BRAF v600-WTClinical management and genomic profiling of pediatric low-grade gliomas in Saudi
ArabiaCorrelating genetic signature of pilomyxoid astrocytomas and pilocytic astrocytomas
with qualitative and quantitative MR imaging characteristics
Spinal low-grade gliomas in Canadian children: a multi-centre retrospective review

Characterizing temporal genomic heterogeneity in pediatric low grade gliomas: Analysis
Margot Lazowof an expanded multi-institutional cohort with 101 paired tumor samples
MR-guided laser interstitial thermal therapy for unresectable and symptomatic pediatricDavid Kram
low grade glioma
Diffuse leptomeningeal glioneuronal tumor (DLGNT) in children: different clinicalAndge Valiakhmetova
presentations and outcomes

Carboplatin-induced hematuria in a pediatric patient with low-grade glioma and review
of literature
Excellent clinical / radiological response to BRAF inhibition in a young child with inoperable supra-sellar pilocytic astrocytoma
Trametinib-associated hyponatremia in a child with low grade glioma is not seen
following treatment with alternative MEK inhibitor
Systemic therapy of rosette-forming glioneuronal tumor of the fourth ventricle in anadolescent
A brain tumor diagnosed after transition to the Department of Adult Neurosurgery fromthe Department of Pediatrics
Desmoplastic infantile ganglioglioma (DIG) with a PPP1CB-ALK fusion in a 6-year-oldgirl
Bevacizumab-associated secondary amenorrhea and premature ovarian failure inadolescent female patients with low-grade CNS disease

Pilomyxoid astrocytoma of the cervical spinal cord in a 7-year-old Armenian boy: A
case report
Prolific growth of BRAF V600E mutant pilocytic astrocytoma while on ketogenic diet:
Case Report

USACanada
USA

USA
USA
Russia